LONDON, March 27, 2017
Proventa International, a market intelligence consultancy for Life Sciences and Healthcare sectors, are pleased to announce the appointment of Richard Lingard as General Manager of Commercial Operations. The evolution of Proventa’s information based products and services will be driven by Richard Lingard as he structures the company for sustained growth.
“I’m excited about joining Proventa International, their success is driven by high quality products and services,” said Richard Lingard. “Proventa International are at the forefront of market intelligence consultancy to niche sectors in the Life Science industry. I look forward to developing their offerings for Life Sciences and Healthcare.”
Co-Founder & Managing Director Louis Smikle added, “We are delighted to welcome Richard to Proventa International. His expertise in commercial operations, building teams and growing organisations profitably, will be valuable as we expand our geographical reach and capabilities in the Life Sciences and Healthcare sector.”
Co-Founder & Managing Director Leo Codilla-Failma said: “Richard will be responsible for executing the company strategy as we are to expand our core business, and the scope of our organisation.”
Richard Lingard brings significant management and industry experience having worked in the Life Sciences industry for two and a half decades supporting pharmaceutical organizations’ drug discovery efforts. As a Director at Thomson Reuters (now Clarivate Analytics) initially for Europe, Middle East and Africa, then globally, he expanded sales, and routes to market. Richard’s last role was at Dotmatics Limited, as the Senior Vice President of Commercial Operations, where he grew revenue & net profit margin significantly by expanding sales and operations in; North America, Europe, Asia and Japan. Richard Lingard has also held a number of other significant global commercial roles.
About Proventa International
A market intelligence consultancy specialising in the Life Science and Healthcare sectors, working with Pharmaceutical, Biotechnology and Academic Institutions worldwide. By creating a knowledge network of strategic executive partnerships, we are able to engage and bring true innovation through our global stakeholders, shortening timelines and helping to achieve their vision.